Gaurica Chacko’s Post

🎉 Happy International Women's Day 2024! 🎉 Today is a celebration of the incredible strength, resilience, and achievements of women around the globe, and a call to embrace this year's theme: 'Inspire Inclusion.' On this day, we reflect on the importance of inclusivity in every aspect of our lives, including healthcare. For too long, women have been underrepresented in clinical trials, leading to gaps in our understanding of how treatments affect different genders. But there's hope on the horizon 👏. Thanks to ongoing efforts and advocacy, we're seeing huge progress in the representation of women in research 🚺. Healthcare professionals are supporting the inclusion of diverse participants in studies to ensure that medical interventions are safe and effective for everyone. Every woman's voice matters, and her health and well-being deserve to be prioritized 🏥. Let's inspire inclusion not just today, but every day. Together, we can create a more equitable and inclusive world for all 🌍. To learn more about the history and evolution of women’s representation in clinical trials, read this article from Medable, Inc’s Camila Matheny ➡️: https://lnkd.in/eWxpgXbW ________ #IWD2024 #InspireInclusion #clinicaltrials #clinicalresearch

🔬𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐢𝐧𝐠 𝐆𝐞𝐧𝐝𝐞𝐫 𝐃𝐢𝐬𝐩𝐚𝐫𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬: Somer Baburek, MBA sheds a light on women’s exclusion in clinical trials in a thought-provoking article published in Clinical Leader.* Women have been persistently underrepresented in medical research, leading to skewed outcomes and a limited understanding of ailments primarily affecting them. In this piece, Somer delves into the challenges faced across multiple facets – from recruitment to obtaining accurate diagnoses and treatments. While there is a glimmer of progress in women’s presence as scientists and policy change advocates, the goal of true gender equity is far from over. We must ensure representation in order to combat gender bias in clinical trials – so no one is left behind! Read the full article below: https://lnkd.in/dNFeV2NW   #Clincase #ClincaseResearch #ClinicalDataManagement

Hey, folx! I'm super excited to share that I'll be participating as a speaker in an upcoming webinar on improving diversity and inclusion for the LGBTQIA+ community in clinical trials. Current efforts often fall short when it comes to ensuring proper representation and creating an inclusive environment for LGBTQIA+ patients. This webinar aims to tackle that head-on by exploring ways sponsors can smooth the journey for these participants. We'll be diving into important topics like using gender-neutral protocols, making trial communication more inclusive, understanding the FDA's latest draft guidance on diversity plans and data collection, and the crucial roles sites and investigators play. Here are some key things you can expect to learn: 🌟 The basics (and limitations) of the FDA's diversity plan requirements 🌟 Why including LGBTQIA+ participants in trials is so important 🌟 How technology can help capture sexual orientation and gender identity (SOGI) data Mark your calendars for July 10, 2024, from 12-1 PM ET! I'm truly honored to have been invited as a speaker, alongside Fenwick Eckhardt, Shir Netanel, MS, MBA, and Garo Kiledjian to participate in this fantastic educational opportunity. Representation and inclusivity in clinical research are causes very close to my heart, and I can't wait to share insights and have enriching discussions. #LGBTQIA #GenderIdentity #SexualOrientation #ClinicalTrials #ClinicalResearch #Inclusion #Diversity #Education #Patients #ACRP

👉🚺Improving women’s health starts with research. History shows that medical research has often neglected women. We at Swissmedic are working to resolve this inequality. Our new guidelines are designed to increase women’s participation in clinical trials and ensure that medicines are safe and effective for them as well as for men. Together for greater gender equality in medicine ♀️⚖️♂️ #Healthcare #Swissmedic #WomensHealth #GenderMedicine

This year for International Women's Day, the theme is ‘Inspire Inclusion’. Inclusivity in medical research is crucial to helping women make informed decisions. This article details how research, including studies published in MDPI journals, is helping to bridge this gap and advocate for women's inclusion. Learn more: https://brnw.ch/21wHEyg #IWD2024 #InspireInclusion

You can’t manufacture trust. Recently, the FDA's Office of Minority Health and Health Equity engaged with researchers, patients, community members, LGBTQ+ health professionals, and advocates to address #clinicaltrial representation from the #LGBTQ+ community. It's encouraging to witness the FDA initiating direct dialogue on this crucial matter and exploring strategies to tackle lower clinical trial participation rates. Throughout the clinical trial process, the LGBTQ+ community faces unique challenges, starting with informed consent forms that often lack inclusive options for collecting data representative of the LGBTQ+ community. The hurdles extend to issues like lack of trust, limited LGBTQ+ health care expertise among providers, and scarce trials tailored to the community's needs. Addressing these challenges is a long-term endeavor, and the FDA's proactive approach in convening such crucial meetings signifies a step in the right direction towards finding solutions. Learn more about advancing clinical trial participation for the LGBTQIA+ community here: https://lnkd.in/e6Kkj75R

Based on insights from the recent #WOCIP conference, our team has outlined how organizations in the #LifeSciences industry can go about achieving #HealthEquity in 2025, with a focus on representation, patient-centricity, and industry trends. Here is part two of our takeaways from the 8th Annual Women of Color in Pharma conference: https://lnkd.in/ekRKdAR4

Based on insights from the recent #WOCIP conference, our team has outlined how organizations in the #LifeSciences industry can go about achieving #HealthEquity in 2025, with a focus on representation, patient-centricity, and industry trends. Here is part two of our takeaways from the 8th Annual Women of Color in Pharma conference: https://lnkd.in/dTFMvaBX

Based on insights from the recent #WOCIP conference, our team has outlined how organizations in the #LifeSciences industry can go about achieving #HealthEquity in 2025, with a focus on representation, patient-centricity, and industry trends. Here is part two of our takeaways from the 8th Annual Women of Color in Pharma conference: https://lnkd.in/eUTGyMKi

Based on insights from the recent #WOCIP conference, our team has outlined how organizations in the #LifeSciences industry can go about achieving #HealthEquity in 2025, with a focus on representation, patient-centricity, and industry trends. Here is part two of our takeaways from the 8th Annual Women of Color in Pharma conference: https://lnkd.in/eBdWDDXc